BLOOMINGTON, Ind. – George Ball, associate professor of operations and decision technologies and Weimer Faculty Fellow at the Indiana University Kelley School of Business, has been invited to join a national advisory committee studying the security of the U.S. medical product supply chain.
The ad hoc committee, established by the National Academies of Sciences, Engineering and Medicine in response to the Coronavirus Aid, Relief and Economic Security (CARES) Act, has been tasked with assessing and evaluating the dependence of the United States on critical drugs and devices that are sourced or manufactured outside of the United States and provide recommendations to improve the resiliency of the medical supply chain.
“Recent disasters and health emergencies including, but not limited to COVID-19, have increased recognition of the fragility of the U.S. medical supply chain,” reads the study’s description. “In the past several years, consolidation, competition and the push for greater efficiency has led hospitals and healthcare systems to retain a more limited supply of drugs and medical devices on hand, adding additional stress to existing logistical challenges.
“Previous efforts have identified these supply chain issues generally as both a public health and national security risk, but only limited research has been conducted into the impact of shortages on patient care, the potential policy, regulatory and systems solutions that could help better prevent and mitigate the impact of shortages and the economic costs or incentives of implementing significant changes.”
“I am honored to have the opportunity to join this outstanding committee. Our work has important ramifications for U.S. public health.” Ball said.